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1. Introduction 
,In the early nineteen-fifties Hokin and Hokin 
found that pancreatic exocrine tissue, when induced 
to secrete digestive enzymes by the addition of acetyl- 
choline or pancreozymin, showed a greatly increased 
rate of uptake of 32P into its phospholipids [ 1,2] . 
Acetylcholine also provoked increases in phospho- 
lipid metabolism in cerebral cortex slices, avian salt 
gland and in secretory tissues other than pancreas 
[3-S]. They later showed that these changes were 
largely confined to the metabolism of phosphatidyl- 
inositol (PI-structure I) and of a precursor, phospha- 
tidic acid (PA-structure II). There was much less 
change in the labelling of the other phospholipids, 
even though these constituted the bulk of the lipids 
of the tissues. These and subsequent studies of ner- 
vous and secretory tissues have been reviewed by 
Hokin [5-81 and by Hawthorne [9] . 
?- 
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It has become apparent in the last few years that a 
rapid enhancement of phosphatidylinositol turnover 
occurs in a wide range of different types of stimulated 
tissue and that this response may be evoked by a vari- 
ety of stimuli (table 1). It now seems appropriate to 
broaden the discussions to include the available infor- 
mation from all types of tissues, in the hope that this 
may help in the explanation of this rather widespread 
response. Throughout this review we shall therefore 
make the assumption, unproven but supported by the 
similarity of the metabolic events seen in many sys- 
tems, that the mechanism underlying enhanced PI 
turnover is the same in all tissues. The experimental 
observations which are discussed are derived mainly 
from studies of nervous tissues (cerebral cortex, sym- 
pathetic ganglia), secretory tissues (adrenal medulla, 
parotid, pancreas, pineal), lymphocytes and polymor- 
phonuclear leucocytes. 
Previous discussions of enhanced PI turnover have 
usually emphasized the possible significance of the in- 
terconversion of small quantities of particular lipids 
in the affected cells and the consequences of such 
changes in terms of the functioning of the membranes 
modified thereby [5- 131. It is equally valid, however, 
to consider the possible significance of the rapid re- 
moval and replacement (i.e. turnover) of the water- 
soluble phosphorylinositol portion of PI and one re- 
cent suggestion has been based on a mechanism of the 
latter type [ 141. We will attempt to consider the rela- 
tive merits of these two types of interpretation. Our 
conclusion is that such an analysis strongly favours 
mechanisms of the latter type and a model is pro- 
posed for the intracellular events which appears to be 
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Fig. 1. Biosynthesis of phosphatidylinositol and turnover of its phosphorylinositol group. PI, phosphatidylinositol: PA, phospha- 
tidic acid. 
consistent with considerably more of the experimen- 
tal evidence than were the previous suggestions. 
2. The pattern of reactions involved 
Synthesis of PI de novo follows the pathway 
shown in fig. 1 and in some tissues enhanced labelling 
is due to synthesis of complete PI molecules via this 
route (pancreas [5], thyroid [ 151). In other systems, 
however, the pattern of incorporation of labelled pre- 
cursors indicates that during stimulated PI turnover 
only the phosphorylinositol portion of the molecule 
shows enhanced turnover (cerebral cortex [6,16], 
lymphocytes [ 17,181, polymorphonuclear leucocytes 
[19,20], adrenal medulla [21]). This is thought to 
occur by a cycle of reactions which is also shown in 
fig. 1 [4,10,13,22]. Any general model for these 
events must therefore include a mechanism whereby 
the 1,2-diacylglycerol portion of the molecule can be 
conserved and utilised for resynthesis of PI. 
3. The tissues showing enhanced PI turnover and the 
stimuli which provoke the effect 
These are summarised in table 1. Many of the tis- 
sues listed are nervous or secretory and often the stim- 
uli in successful experiments have been cholinergic or 
electrical (parasympathetic, sympathetic or non-spe- 
cific). This seems, though, to have been largely a re- 
flection of the interests of individual investigators 
and the hypotheses available for investigation; clearly 
many combinations of tissues and stimuli have given 
positive results. Many of the stimuli listed are known 
to interact with cells via cell surface receptors (insulin, 
acetylcholine, phytohaemagglutinin, adrenaline, thy- 
rotrophin). There are, however, some situations 
where activation of cell-surface receptors has not pro- 
vided a specific enhancement of PI turnover (eg. ef- 
fects of glucagon [43] ), so it does not seem that this 
is merely a generalised response to any extracellular 
stimulus mediated through cell-surface receptors. 
The observed change in PI labelling on stimulation 
is usually at least a doubling and in some systems 
may be as much as tenfold. 
The effect of cinchocaine, a local anaesthetic 
[25,30,36] and of phentolamine and propranolol, 
which are agents used for producing blockade, respec- 
tively, of adrenergic cr- and /I-receptors, clearly does 
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Table 1 
Tissues which show enhanced PI turnover and the stimuli evoking this response*. 
Tissue 
-____ 
Stimulus References 
Cerebral cortex 
Sympathetic ganglia 
Vagus nerve 
Pancreas 
Submaxillary 
gland 
Parotid gland 
Adrenal medulla 
Thyroid 
Gastric mucosa 
Anterior pituitary 
Pineal 
Sweat glands 
Salt gland (avian) 
Polymorphonuclear 
leucocytes (and other 
phagocytes) 
Heart 
Adipose tissue 
Lymphocytes 
Fibroblasts*qown to 
confluence 
Acetylcholine, electrical 
Acetylcholme, electrical 
Cinchocaine 
Acetylcholine, pancreozymin, caerulein 
Acetylcholine, adrenaline, electrical 
(sympathetic or parasympathetic) 
Acetylcholine, adrenaline, cinchocaine, 
propranolol, phentolamine 
Acetylcholine- 
Thyroid stimulating hormone, long-acting 
thyroid stimulator, propranolol 
Histamine, acetylcholine 
Corticotrophin-releasing factor 
Noradrenaline, cinchocaine, propranolol, 
phentolamine 
Acetylcholine 
Acetylcholine 
Phagocytizable particles, digitonin, 
deoxycholate, bacterial endotoxin 
Adrenalin 
Insulin 
Phytohaemagglutin, anti-lymphocyte antiserum 
Addition of fresh serum 
]6,13,231 
h 13,241 
WI 
[5,7,8,26,271 
]5,7,281 
]5,7,29,301 
[5,7,211 
[5,7,15,31-35,461 
]5,71 
I5771 
1361 
[5>71 
I41 
[19,20,37] 
1381 
[391 
[17,18,40,41] 
1421 
* Where possible recent references involving some discussion are given. Original references may be found therein. 
** Turnover was measured as loss of label from PI on stimulation. 
not fit into this picture. It does seem, however, that 
clnchocaine and propranolol probably share a common 
mode of action based on local anaesthetic properties 
common to both, and that phentolamine acts via 
some route other than that adrenergic a-blockade [36] . 
4. How are the changes in PI metabolism linked to in- 
teraction of ligands with extracellular receptors? 
In principle this might be either via the mediation 
of CAMP (or of another, as yet unidentified, second 
messenger) or through a direct functional link at the 
cell surface membrane between one of the enzymes 
involved in the modified PI metabolism and the recep 
tor. Mediation by CAMP has been ruled out for parot- 
id [29,44], pancreas [26,27,45] thyroid [31-35,461 
and pineal [36]. In these tissues studies with 
extracellular stimuli, with CAMP and its dibutyryl de- 
rivative, and with inhibitors of CAMP phosphodiester- 
ase have all shown that, whereas secretion and certain 
other cellular events are mediated via CAMP, the 
changes in PI metabolism are not correlated in any 
consistent way with the levels of tissue CAMP. It thus 
appears likely that mediation of this effect is via ei- 
ther direct effects on a cell-surface receptor or through 
control by a second messenger other than CAMP. 
5. Which step in the cycle is controlled? 
The stimulation, in some tissues, of the turnover of 
only the phosphorylinositol group suggests that the 
stimulus occurs at either the conversion of phospha- 
tidylinositol to 1,2-diacylglycerol or of the latter to 
phosphatidic acid, as these are the steps not involved 
in synthesis of phosphatidylinositol de novo (fig. 1). 
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This conclusion is supported by the ability of gam- 
mexane (a hexachlorocyclohexane with a conforma- 
tion somewhat related to that of myoinositol) to 
block the stimulated labelling without affecting the 
normal rate of phosphatidylinositol biosynthesis de 
novo [40,47] , Both reactions in the conversion of PI 
to phosphatidic acid are now known to be localised at 
least partially in the cell surface membrane in cerebral 
cortex [23,48] , suggesting that one or other could be 
directly linked to the cell surface receptors; both have 
been suggested in the past as the site of action of 
extracellular stimuli [ 10, 18,22,49] 
Although we have not ourselves observed any di- 
rect effect of stimulation on either the cleavage of 
phosphatidylinositol (unpublished results) or the 
phosphorylation of diglyceride [23] we tentatively 
ascribe the site of action of the stimulus to the former 
reaction for several reasons. a) There is a limited 
amount of direct evidence for such a link in cerebral 
cortex [ 10,501 . b) If 32P-labelled lymphocytes are 
stimulated in the presence of 31P then radioactivity is 
rapidly “chased” from phosphatidylinositol [ 171. 
Stimulation of 1,2-diacylglycerol phosphokinase 
would not have this effect. c) An effect cited as evi- 
dence for stimulation by phytohaemagglutinin of 1,2- 
diacylglycerol kinase, assayed in lymphocyte plasma 
membranes using endogenous substrate and 
[32P]ATP [ 181, can equally be interpreted as evi- 
dence for a raised 1 ,Zdiacylglycerol concentration in 
the membranes. This would be a consequence of in- 
creased phosphatidylinositol breakdown. d) Control 
would be expected at the first, not the second, step of 
a pathway. e) Finally, the evidence which has been 
presented relating to control of diacylglycerol kinase 
has been either open to alternative interpretations 
[5-7,18,51] or negative [23,52] ; it is not clear how 
the whole cycle of reactions could be stimulated, 
with reutilisation of the diglyceride, if this were the 
controlled step. 
6. What are the events in lipid metabolism which fol- 
low stimulation and where in the cell do the la- 
belled lipids appear? 
After cleavage of PI it seems that two alternative 
routes are taken by different tissues. In some, the 
4 
released 1,2-diacylglycerol is specifically utilised for 
resynthesis of PI, and in others it is dismantled and 
the cells renew their PI complement by synthesis of 
new PI molecules de novo. As would be expected, 
the kinetics of PA and PI labelling in stimulated cells 
are consistent with a precursor-product relationship 
between these two lipids [5,21,53]. 
Autoradiographic studies by Hokin indicated that 
newly-labelled PI was distributed in all of the mem- 
branes of stimulated cells [7]. This important obser- 
vation has been directly confirmed by studies of the 
subcellular distribution of the newly synthesised PI 
in lymphocytes, thyroid, pineal, cerebral cortex and 
pancreas which had been stimulated for various peri- 
ods [5,8,12,13,18,36]. In pancreas there is some 
evidence for localisation of the newly-synthesised PI 
in endoplasmic reticular membranes [5,8] but there 
is no evidence from any of these systems for an ex- 
pected localisation of this lipid at the cell surface. In 
contrast, in the lymphocyte the newly-labelled phos- 
phatidic acid was at least partially localised in surface 
membranes [ 181. 
7. Where are the enzymes of the cycle located? 
An enzyme cleaving PI is a constituent of the cyto- 
sol of many tissues, but its acid pH optimum and 
cytoplasmic localisation do not make it a suitable can- 
didate for a role in the effects being discussed [ 14,481 . 
A role for this enzyme in microtubule function has 
recently been suggested [54]. 
A membrane-bound enzyme catalysing PI cleavage 
was recently found in cerebral cortex [ 14,48,50] . 
Both this and 1,2-diacylglycerol phosphokinase are 
present in the cell surface in cerebral cortex to an ap- 
preciable extent [23,48] . The enzymes which cata. 
lyse conversion of PA to PI are, however, located in 
intracellular membranes [55-621 . 
8. General considerations of eeIIular metabofism 
There is a considerable body of evidence which in- 
dicates that the enhancements of PI and PA labelling 
are not trivial consequences of changes in sizes or spe- 
cific activities of the cellular pools of Pi 
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[21,28,38,53,63-651, ATP [20,21,28,38,53, 
63-651, or 3glycerophosphate [ 20,641. 
9. General considerations of membrane dynamics 
Recent evidence has indicated that the constit- 
uents of cell membranes are in a highly fluid and dy- 
namic state in at least three different senses: 
i) Lipid molecules are not able to rapidly move 
from one face to the other in a lipid bilayer, but do 
diffuse laterally in the plane of a lipid layer very rapid- 
1Y 1661. 
ii) Proteins on the cell surface move laterally rela- 
tively rapidly [67-691. 
iii) Phospholipids move rapidly between different 
intracellular membranes by a process catalysed by spe- 
cific soluble cytoplasmic proteins [70-721. 
10. Models based on local changes in the lipids of 
membranes: an assessment 
Proposed explanations for modified PI metabolism 
in various systems have usually relied on the idea that 
the key change which occurs is an interconversion of 
PI and PA, or of PI and 1 ,Zdiacylglycerol, at highly 
localised sites in membranes. The hypotheses included 
suggestions for either (a) a direct role of such inter- 
conversions in neurotransmission [ 10,731 or other 
processes linked to cell-surface receptors [ 11,151, 
(b) a role in controlling a cell-surface phenomenon 
such as salt-pumping [4] , (c) participation in the 
membrane flux accompanying secretion [5,7], or (d) 
a longer-term role in the changes provoked by stimuli 
which produce adaptive responses [ 14,18,34,74] , 
The former two alternatives are relatively short- 
term and have been very difficult to sustain on kinetic 
grounds [5,6,10, 11,751 . The last alternative has 
been little investigated, but the relationship of en- 
hanced PI turnover to secretion has been thoroughly 
analysed and many factors now rule out a direct rela- 
tionship between the two processes. These include: 
i) Blockage of secretion, but not the lipid effect, by 
Ca2+ omission [76,77] . ii) Control of secretion and 
other metabolic effects, but not PI turnover, through 
CAMP (see above), iii) Differences in the dose-response 
relationships for the two processes, with PI turnover 
requiring either a greater [74] or lesser [32] level of 
stimulation, and iv) a lack of correlation between the 
time-courses of the two processes [8]. 
Thus there is little experimental support for the 
previous hypotheses involving local modifications to 
membranes. In addition, there are general arguments 
which suggest hat such hypotheses will not provide 
a satisfactory explanation of such phenomena. The 
nature of these hypotheses is such that the turnover 
of a restricted pool of PI would usually have to occur 
in and be confined to specific cellular sites, often the 
surface membrane [ 10, 1 1,13,15] . The material sum 
marised above suggests, however, that within stimu- 
lated cells the “responsive” fraction of the PI is not 
localised, rather it is in equilibrium with the bulk of 
the PI in all membranes of the cells. There is no evi- 
dence for the presence of all the enzymes involved in 
PI turnover at any single site in the cell. Further, it is 
difficult to see how any such models could be easily 
reconciled with the fluidity of membranes and the 
rapidity with which phospholipids originating at sin- 
gle sites reach equilibrium throughout the membranes 
of a cell. 
11. Models based on a function for a water-soluble 
product resulting from PI turnover 
The water-soluble products of the reactions in- 
volved in PI turnover appeared, until recently, to be 
ADP, PPi, CMP and myoinositol l-phosphate (III), 
none of which attracted much interest in discussion 
of the effects of stimulation. The recent identification 
of myoinositol 1,2cyclic phosphate (IV) as a product 
of PI cleavage [78], and the subsequent discovery of 
a surface membrane enzyme catalysing its production 
[48] and a phosphodiesterase catalysing its break- 
down [79] have changed this situation. As a result 
we suggested that a primary response of cells to extra- 
cellular stimuli may be production, by cleavage of PI, 
of intracellular myoinositol 1,2-cyclic phosphate, and 
that the observed changes in PA and PI metabolism 
may reflect renewal of the PI pool of the cell [ 141. 
This suggestion attaches special significance to the 
cleavage of PI, which is the enzymic step which we 
have concluded from other evidence to be the most 
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likely site of action of stimuli on PI metabolism (see 
above). We have therefore attempted to put together 
a likely model of intracellular events in lipid metabo- 
lism subsequent o cleavage of PI to yield 1,2-diacyl- 
glycerol at the cell surface, and to assess its compati- 
bility with the evidence discussed earlier. The result 
is shown in fig. 2. 
We suggest hat the 1,2-diacylglycerol released in 
the cell surface membrane is either destroyed by 
diacylglycerol lipase [80] or rapidly converted to PA 
by diacylglycerol kinase. The latter mechanism would 
provide a method whereby in certain tissues the 
diacylglycerol backbone of cleaved PI could be con- 
served. The surface membrane enzymes catalysing PI 
cleavage and phosphorylation of 1,2-diacylglycerol 
are both activated by deoxycholate at similar concen- 
trations [23,48]. This may reflect an “uncoupling” 
of two tightly bound enzymes, the detergent solu- 
bilising the enzymes and substrates and also breaking 
a tight functional link whereby diacylglycerol re- 
leased from PI is passed in an enclosed hydrophobic 
environment to 1 ,ZdiacylgIycerol phosphokinase. 
The enzymes which catalyse conversion of phos- 
phatidic acid to phosphatidylinositol are not located 
in the cell surface; therefore the phosphatidic acid 
which has been synthesised there must be moved else- 
where before completion of its conversion back to 
phosphatidylinositol. Similarly, the final step of 
EXTRACELLULAR MEDIUM 
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PI 14. 1,2-diacylqlycerol @ PA 
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Exchange 
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3-qlycrrophoxphata 
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Fig. 2. A suggested model for the events which occur in a stimulated cell which shows enhanced phosphatidylinositol turnover. 
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phosphatidylinositol biosynthesis occurs in the endo- 
plasmic reticulum, and there must be some mecha- 
nism for distribution of the synthesised lipid rapidly 
from here to other membranes. It is likely that these 
movements of phosphatidylinositol and phosphatidic 
acid are achieved by exchange proteins. These cyto- 
plasmic proteins catalyse exchange of phospholipids 
between different membranes within the cell [72] and 
between isolated subcellular fractions in suspension 
[70,71,81-841. Differences have been observed in 
the relative rates of exchange of several phospholipids 
between labelled liver microsomes and unlabelled 
mitochondria in the presence of soluble fractions 
from different tissues. This suggests that several pro- 
teins are present in the cytoplasm of cells, each one 
catalysing exchange of a different phospholipid [ 811. 
This conclusion is supported by the isolation, from a 
liver soluble fraction which catalyses exchange of sev- 
eral lipids, of a protein which catalyses exchange only 
of phosphatidylcholine [83] . In such experiments 
with isolated subcellular fractions, the exchange of 
phosphatidylinositol was rapid in comparison to that 
of other phospholipids [81] and phosphatidic acid ex- 
change was comparable to that of other lipids [84]. 
Experiments with acetylcholine-treated cerebral 
cortex slices [ 131 and phytohaemagglutinin-stimu- 
lated lymphocytes [ 181 suggest hat in these systems 
the phosphatidylinositol exchange within the cells is 
so rapid that equilibration of newly-synthesised lipid 
with the pre-existing lipid is complete in very few min- 
utes. The phosphatidic acid exchange may be some- 
what slower, as accumulation of labelled phosphatidic 
acid can be detected in the plasma membranes of 
lymphocytes after brief stimulation [ 181 and in the 
salt gland much of the lipid that is “cycled” during 
stimulation may accumulate as phosphatidic acid [4]. 
The rapid exchange of PI would not only explain the 
distribution of newly-labelled lipids throughout the 
cells, but could also account for the speed with which 
32P can be chased out of PI, presumably by its break- 
down at the cell surface, when labelled lymphocytes 
are stimulated with phytohaemagglutinin [ 171. 
In fig. 2 the site for both reactions involved in the 
conversion of PA to PI is given as endoplasmic reticu- 
lum membranes. This is based on the known localisa- 
tion of CDP-diglyceride:inositol phosphatidyltransfer- 
ase in microsomal fractions from brain [57-591 and 
on the ability of microsomal preparations from liver 
and brain to convert labelled 3-glycerophosphate to 
phosphatidylinositol [ 55,6 1,621, with evidence for 
a close link between the two enzymes involved in the 
conversion of PA to PI [62] . There is, however, some 
conflict over the intracellular localisation of CTP- 
phosphatidate cytidylyltransferase in different studies. 
It has been reported to be microsomal in liver [60] 
but mitochondrial in brain [57]. This apparent con- 
flict may occur because CDP-diglyceride is a precur- 
sor for both cardiolipin and phosphatidylinositol. 
Cardiolipin synthesis seems to occur in the inner mito- 
chondrial membrane [85] and CDP-diglyceride syn- 
thesised for cardiolipin synthesis would, by virtue of 
the required fatty acid composition [86] , be unsuit- 
able for phosphatidylinositol synthesis. CDP-diglycer- 
ide destined for phosphatidylinositol would be equal- 
ly unsuitable for biosynthesis of cardiolipin [87]. 
Possibly CDP-diglyceride synthesis occurs both in 
endoplasmic reticulum and mitochondria, the former 
product being the precursor for phosphatidylinositol. 
If not, there must be a mechanism for transfering PA 
from plasma membranes to mitochondria and CDP-di- 
glyceride from mitochondria to the endoplasmic retic- 
ulum. 
12. Concluding remarks 
Enhanced PI turnover is a more widespread, and 
thus potentially more interesting, characteristic of 
stimulated cells than has previously been generally ac- 
knowledged. From the above discussion it seems that 
a search for a function of a water-soluble produc; of 
this lipid turnover - possibly myoinositol 1,2-cyclic 
phosphate - may be a fruitful approach to elucidat- 
ing the role in cells of this phenomenon. The working 
model presented here accomodates in a single frame- 
work three key points which have not been recon- 
ciled by any previous proposal: localisation of the pri- 
mary response at the cell surface, mediation of the PI 
response independently of CAMP, and distribution of 
the newly-labelled PI throughout the cell very rapidly. 
It also provides possible explanations for several pre- 
viously puzzling findings, including the localisation of 
newly-synthesised PA in the cell surface membrane of 
stimulated lymphocytes [ 181 and the high activity of 
7 
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tissue soluble fractions in catalysing PI exchange be- 
tween membranes [81]. The fact that compounds 
which are effective metabolic antagonists of inositol 
bear substituents at the 2-position [88] , rather than 
the l-position, may be related to the function of this 
hydroxyl group in forming the cyclic ester. 
It is now of primary interest to study the metabo- 
lism and function of myoinositol 1,2-cyclic phosphate 
in cells. A specific phosphodiesterase which causes its 
breakdown is fairly evenly distributed in tissues, ex- 
cept for disproportionate activity in brush borders of 
the epithelial cells in renal proximal tubules [79,89]. 
This exception may indicate a special function for the 
cyclic ester in these cells, but might also be an expres- 
sion of biological economy as inositol is not rapidly 
synthesised by most tissues. Sequential action in kid- 
ney tubules of this phosphodiesterase, alkaline phos- 
phatase [89] and an inositol-accumulating system 
[90] would prevent a loss into the urine of myoinosi- 
to1. 
At present enhanced PI turnover, which probably 
reflects raised tissue levels of cyclic inositol phosphate, 
has no known functions. Control of neurotransmis- 
sion and the secretion of macromoleculis, the two 
processes with which a link was suggested by earlier 
work on PI turnover, are probably not directly related 
to the lipid turnover. An approach to this problem 
might emerge from one or both of the following 
clues. First, changed PI turnover appears to be some- 
how linked to adaptive changes in cells [ 11,18,34,42, 
741. Secondly, enhanced PI turnover is not mediated 
by a mechanism involving CAMP and often, though 
not always, stimuli which evoke PI turnover either de- 
press or do not change the tissue levels of CAMP (a- 
adrenergic [91] , insulin [92], serum stimulation [93], 
acetylcholine [94] ): insight into these systems might 
come from experiments which seek for controls on 
metabolism which produce effects opposite to those 
produced by CAMP. 
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